Medicines A-to-Z

Drug name	NICE TAs	Comments
Soluble insulin		Hospital only
Somapacitan (Sogroya®)		NICE TA 1066 Somapacitan for treating growth hormone deficiency in people 3 to 17 years
Somatrogon (Ngenla®)	TA863 - Somatrogon for treating growth disturbance in children and young people aged 3 years and over
Somatropin injection	TA188 - Human growth hormone (somatropin) for the treatment of growth failure in children (review) TA64 - Growth hormone deficiency (adults) - human growth hormone
Sorafenib tablets	TA178 - Bevacizumab (first-line), sorafenib (first- and second-line), sunitinib (second-line) and temsirolimus (first-line) for the treatment of advanced and/or metastatic renal cell carcinoma TA474 - Sorafenib for treating advanced hepatocellular carcinoma	National CDF list. Negative outcome - CDF funded.
Sotalol
Sotrovimab (Xevudy®)	TA878 - Casirivimab plus imdevimab, nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19
Spacer device		Able Spacer® - For use with all pressurised (aerosol) inhalers AeroChamber® Plus - For use with all pressurised (aerosol) inhalers Volumatic® - For use with Clenil Modulite®, Flixotide®, Seretide®, Serevent®, and Ventolin® inhalers
Spesolimab (Spevigo®)	NICE TA1070 Spesolimab for treating generalised pustular psoriasis flares
Spironolactone tablets		Retains potassium. Useful in liver cirrhosis and congestive heart failure with loop diuretic. Monitor potassium levels carefully.

Soluble insulin

Hospital only

Somapacitan (Sogroya®)

NICE TA 1066 Somapacitan for treating growth hormone deficiency in people 3 to 17 years

Somatrogon (Ngenla®)

TA863 - Somatrogon for treating growth disturbance in children and young people aged 3 years and over

Somatropin injection

TA188 - Human growth hormone (somatropin) for the treatment of growth failure in children (review)
TA64 - Growth hormone deficiency (adults) - human growth hormone

Sorafenib tablets

TA178 - Bevacizumab (first-line), sorafenib (first- and second-line), sunitinib (second-line) and temsirolimus (first-line) for the treatment of advanced and/or metastatic renal cell carcinoma
TA474 - Sorafenib for treating advanced hepatocellular carcinoma

National CDF list. Negative outcome - CDF funded.

Sotalol

Sotrovimab (Xevudy®)

TA878 - Casirivimab plus imdevimab, nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19

Spacer device

Able Spacer® - For use with all pressurised (aerosol) inhalers
AeroChamber® Plus - For use with all pressurised (aerosol) inhalers
Volumatic® - For use with Clenil Modulite®, Flixotide®, Seretide®, Serevent®, and Ventolin® inhalers

Spesolimab (Spevigo®)

NICE TA1070 Spesolimab for treating generalised pustular psoriasis flares

Spironolactone tablets

Retains potassium. Useful in liver cirrhosis and congestive heart failure with loop diuretic. Monitor potassium levels carefully.

University Hospitals Birmingham NHS Foundation Trust

Medicines Formulary

Medicines A–Z

S